Mercy Medical Center gastroenterologist Dr. Raymond Cross explains how ulcerative colitis contributes to cancer risk.
Infliximab, subcutaneous anti-TNF agents, and ustekinumab show comparable effectiveness as second-line therapies in patients with ulcerative colitis after vedolizumab failure.
AI could help predict which patients with ulcerative colitis and low-grade dysplasia will progress to colorectal cancer.In an ...
A new clinical trial suggests that what people eat could finally offer real relief for Crohn’s disease, a condition that has long lacked clear dietary guidance. Researchers found that a ...
Love Island winner Toni Laites speaks about her journey with chronic illness, her experiences in the villa, and her struggles ...
Celebrating 15 years of impact, the program supports Canadian students with Crohn’s disease or ulcerative colitis with fifteen $5,000 scholarships in 2026 ...
WHEN Julie Hughes woke up from a deep coma, she couldn’t remember Scott – her husband and the father of her two kids. Only ...
Ulcerative colitis affects your colon, so the main symptoms include stomach pain, diarrhea, and other issues in your gut. But the disease can also affect other parts of your body, such as your joints, ...
A ll her life, Abigail Marie VanHoose, 31, dreamed of becoming a chef. But just as she was starting to climb the culinary ladder, working on a sauté line at a busy restaurant in North Carolina, she ...
When you’re first diagnosed with ulcerative colitis (UC), there can be a sense of relief in knowing that you finally have an answer to medical issues that you’ve been struggling with. But managing the ...
Since your ulcerative colitis (UC) diagnosis, you did everything your doctor told you to do — took your medication as prescribed, watched what you ate, and managed your stress. And you started to feel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results